Leukemia Clinical Trials in Dallas

Showing 661-670 of 670 trials

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

NCT00088088

This study is for patients who have Stage IIIb or Stage IV NSCLC and have never had chemotherapy before for their disease. The first phase of the study recently completed and for the second phase of the study patients are randomly assigned to receive either paclitaxel and carboplatin or paclitaxel and carboplatin and study drug (STA 4783). Treatment will be every 3 weeks for 6 cycles.

Stage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer

Synta Pharmaceuticals Corp.86 participantsStarted Mar 2004

Jonesboro, Arkansas, United States • Pomona, California, United States • San Francisco, California, United States +16 more locations

COMPLETEDPHASE2< 1 mile

Amonafide in Combination With Cytarabine in Secondary AML

NCT00273884

This protocol is designed to assess the safety and efficacy of amonafide in combination with cytarabine in subjects with previously untreated secondary AML.

Acute Myeloid Leukemia

Xanthus Pharmaceuticals, Inc.80 participantsStarted Aug 2005

Birmingham, Alabama, United States • Duarte, California, United States • Los Angeles, California, United States +18 more locations

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Amonafide in Combination With Cytarabine in Secondary AML

Leukemia Trials in Other Cities

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

CP-481,715 Nickel Allergy Study.

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

Other Conditions in Dallas